WO2003018580A1 - Dérivés de naphthyridine - Google Patents

Dérivés de naphthyridine Download PDF

Info

Publication number: WO2003018580A1
Authority: WO; WIPO (PCT)
Prior art keywords: naphthyridine derivative; derivative; treatments; represented; effective
Prior art date: 2001-08-23

Application number

PCT/JP2002/001520

Other languages

English (en)

French (fr)

Inventor

Tadao Shibutani

Original Assignee

Otsuka Pharmaceutical Factory, Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-08-23

Filing date

2002-02-21

Publication date

2003-03-06

2001-08-23 Priority claimed from JP2001252565A external-priority patent/JP2002138089A/ja

2002-02-21 Application filed by Otsuka Pharmaceutical Factory, Inc. filed Critical Otsuka Pharmaceutical Factory, Inc.

2002-02-21 Priority to KR1020047002463A priority Critical patent/KR100618006B1/ko

2002-02-21 Priority to CA2457451A priority patent/CA2457451C/en

2002-02-21 Priority to US10/487,209 priority patent/US7071187B2/en

2002-02-21 Priority to EP02700656A priority patent/EP1426374A4/en

2002-02-21 Priority to AU2002233664A priority patent/AU2002233664B2/en

2003-03-06 Publication of WO2003018580A1 publication Critical patent/WO2003018580A1/ja

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Diabetes (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Pain & Pain Management (AREA)
Emergency Medicine (AREA)
Rheumatology (AREA)
Endocrinology (AREA)
Hematology (AREA)
Obesity (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

PCT/JP2002/001520 2001-08-23 2002-02-21 Dérivés de naphthyridine WO2003018580A1 (fr)

Priority Applications (5)

Application Number	Priority Date	Filing Date	Title
KR1020047002463A KR100618006B1 (ko)	2001-08-23	2002-02-21	나프티리딘 유도체
CA2457451A CA2457451C (en)	2001-08-23	2002-02-21	Naphthyridine derivatives
US10/487,209 US7071187B2 (en)	2001-08-23	2002-02-21	Naphthyridine derivatives
EP02700656A EP1426374A4 (en)	2001-08-23	2002-02-21	naphthyridine
AU2002233664A AU2002233664B2 (en)	2001-08-23	2002-02-21	Naphthyridine derivative

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP2001-252565		2001-08-23
JP2001252565A JP2002138089A (ja)	2000-08-23	2001-08-23	ナフチリジン誘導体

Publications (1)

Publication Number	Publication Date
WO2003018580A1 true WO2003018580A1 (fr)	2003-03-06

Family

ID=19081017

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PCT/JP2002/001520 WO2003018580A1 (fr)	2001-08-23	2002-02-21	Dérivés de naphthyridine

Country Status (8)

Country	Link
US (1)	US7071187B2 (ja)
EP (1)	EP1426374A4 (ja)
KR (1)	KR100618006B1 (ja)
CN (1)	CN1266151C (ja)
AU (1)	AU2002233664B2 (ja)
CA (1)	CA2457451C (ja)
TW (1)	TWI247010B (ja)
WO (1)	WO2003018580A1 (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7343624B1 (en) *	2004-07-13	2008-03-11	Sonicwall, Inc.	Managing infectious messages as identified by an attachment
KR101040212B1 (ko) *	2009-05-08	2011-06-16	박병용	필터를 사용하여 이물질을 걸러내는 장치

Citations (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH0517475A (ja) *	1991-07-09	1993-01-26	Sapporo Breweries Ltd	新規な３，４−ジヒドロ−１，８−ナフチリジン誘導体及びそれを含有する抗気管支喘息薬
JPH072779A (ja) *	1993-06-17	1995-01-06	Japan Tobacco Inc	２（１ｈ）−ピリドン誘導体
JPH0710875A (ja) *	1993-06-21	1995-01-13	Green Cross Corp:The	選択的ホスホジエステラーゼｉｖ阻害剤
JPH07304775A (ja) *	1994-03-15	1995-11-21	Otsuka Pharmaceut Factory Inc	ナフチリジン及びピリドピラジン誘導体
WO1999002527A1 (fr) *	1997-07-10	1999-01-21	Otsuka Pharmaceutical Factory, Inc.	Derives de naphthyridine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP4117462B2 (ja) *	2001-07-03	2008-07-16	株式会社大塚製薬工場	ナフチリジンおよびキノリン誘導体

2002
- 2002-02-21 CN CNB028165314A patent/CN1266151C/zh not_active Expired - Fee Related
- 2002-02-21 AU AU2002233664A patent/AU2002233664B2/en not_active Ceased
- 2002-02-21 EP EP02700656A patent/EP1426374A4/en not_active Withdrawn
- 2002-02-21 WO PCT/JP2002/001520 patent/WO2003018580A1/ja active Application Filing
- 2002-02-21 US US10/487,209 patent/US7071187B2/en not_active Expired - Fee Related
- 2002-02-21 KR KR1020047002463A patent/KR100618006B1/ko not_active IP Right Cessation
- 2002-02-21 CA CA2457451A patent/CA2457451C/en not_active Expired - Fee Related
- 2002-02-22 TW TW091103209A patent/TWI247010B/zh not_active IP Right Cessation

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH0517475A (ja) *	1991-07-09	1993-01-26	Sapporo Breweries Ltd	新規な３，４−ジヒドロ−１，８−ナフチリジン誘導体及びそれを含有する抗気管支喘息薬
JPH072779A (ja) *	1993-06-17	1995-01-06	Japan Tobacco Inc	２（１ｈ）−ピリドン誘導体
JPH0710875A (ja) *	1993-06-21	1995-01-13	Green Cross Corp:The	選択的ホスホジエステラーゼｉｖ阻害剤
JPH07304775A (ja) *	1994-03-15	1995-11-21	Otsuka Pharmaceut Factory Inc	ナフチリジン及びピリドピラジン誘導体
WO1999002527A1 (fr) *	1997-07-10	1999-01-21	Otsuka Pharmaceutical Factory, Inc.	Derives de naphthyridine

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP1426374A4 *

Also Published As

Publication number	Publication date
CA2457451A1 (en)	2003-03-06
EP1426374A1 (en)	2004-06-09
CN1547581A (zh)	2004-11-17
KR20040036915A (ko)	2004-05-03
AU2002233664B2 (en)	2007-10-18
CN1266151C (zh)	2006-07-26
EP1426374A4 (en)	2005-08-03
KR100618006B1 (ko)	2006-08-31
US20040214853A1 (en)	2004-10-28
CA2457451C (en)	2010-07-13
TWI247010B (en)	2006-01-11
US7071187B2 (en)	2006-07-04

Publication	Publication Date	Title
WO2002096357A3 (en)	2003-09-25	Conformationally constrained analogs useful as antidiabetic and antiobesity agents and method
GEP20084500B (en)	2008-10-10	Heterocyclocarboxamide derivatives
EP0513387A4 (en)	1993-04-21	Active oxygen inhibitor
WO2001072728A3 (en)	2002-07-18	Novel piperazine derivatives
WO2005041653A3 (de)	2005-07-28	Synergistische fungizide wirkstoffkombinationen
MX9700886A (es)	1998-04-30	Nuevas oxazolidinonas sustituidas.
MY134880A (en)	2007-12-31	Thiazolyl amide derivatives
AU2003243096A1 (en)	2004-01-06	NOVEL PURINE- OR PYRROLOL(2,3-d)PYRIMIDINE-2-CARBONITILES FOR TREATING DISEASES ASSOCIATED WITH CYSTEINE PROTEASE ACTIVITY
HK1071510A1 (en)	2005-07-22	Acetylene derivatives having mglur 5 antagonistic activity
AU2002310768A1 (en)	2003-06-19	Substituted 1-oxa-2,8-diaza-spiro[4,5]dec-2-ene derivatives as medicaments for the treatment of pain
WO2001047928A3 (de)	2002-05-16	Imidazo 1,3,5 triazinone und ihre verwendung
RS99804A (en)	2006-12-15	Novel compounds and their use
WO2002050077A3 (de)	2002-09-12	Triazolopyrimidine
WO2004035800A3 (en)	2004-08-26	Intermediate cefdinir salts
WO2002085291A3 (en)	2003-02-20	Nociceptin analogs
MXPA03009206A (es)	2004-01-29	FORMULACIONES DE 3,7-DIAZABICICLO [3.3.1] COMO COMPUESTOS ANTIARRiTMICOS.
WO2001009122A3 (en)	2001-06-28	Serotonergic benzofurans
EP1671948A4 (en)	2007-03-14	CINNAMOYL COMPOUND AND USE THEREOF
WO2004043928A3 (en)	2004-07-01	N-sulfonyl-4-methyleneamino-3-hydroxy-2-pyridones as antimicrobial agents
EP1671961A4 (en)	2009-04-01	CINNAMOYL COMPOUND AND USE THEREOF
WO2005061496A8 (en)	2006-02-16	Aminopyridine-derivatives as inductible no-synthase inhibitors
WO2003018580A1 (fr)	2003-03-06	Dérivés de naphthyridine
WO2002088125A3 (de)	2003-02-13	Triazolopyrimidine mit fungizider wirkung
WO2002032856A3 (en)	2002-07-04	Insecticidal 1,8-naphthalenedicarboxamides
WO2001010861A3 (de)	2001-09-07	Substituierte heterocyclyl-2h-chromene

Legal Events

Date	Code	Title	Description
2003-03-06	AK	Designated states	Kind code of ref document: A1 Designated state(s): AU CA CN KR US Kind code of ref document: A1 Designated state(s): AU CA CN KR
2003-03-06	AL	Designated countries for regional patents	Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB IE IT LU MC NL PT SE TR Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR
2003-04-03	DFPE	Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
2003-05-02	121	Ep: the epo has been informed by wipo that ep was designated in this application
2004-02-05	WWE	Wipo information: entry into national phase	Ref document number: 2002233664 Country of ref document: AU Ref document number: 2457451 Country of ref document: CA
2004-02-18	WWE	Wipo information: entry into national phase	Ref document number: 10487209 Country of ref document: US
2004-02-20	WWE	Wipo information: entry into national phase	Ref document number: 1020047002463 Country of ref document: KR
2004-02-23	WWE	Wipo information: entry into national phase	Ref document number: 20028165314 Country of ref document: CN
2004-03-04	WWE	Wipo information: entry into national phase	Ref document number: 2002700656 Country of ref document: EP
2004-06-09	WWP	Wipo information: published in national office	Ref document number: 2002700656 Country of ref document: EP